Advise patients to discontinue dapagliflozin and metformin hydrochloride extended-release tablets immediately and to promptly notify their healthcare provider if unexplained hyperventilation, myalgia, malaise, unusual somnolence, dizziness, slow or irregular heartbeat, sensation of feeling cold (especially in the extremities), or other nonspecific symptoms occur
In spite of growing interest in the use of NAD + precursors as a strategy for healthy aging, the in vivo pharmacokinetics remain poorly understood
Tesamorelin, by contrast, is a synthetic analogue of growth hormone-releasing hormone (GHRH)
We anticipate a myostatin inhibitor might launch as early as 2028 and could be priced at US$4,000 per year based on the current price of GLP-1 therapies and the anticipated future competitive pricing that will be offered
If experienced stop usage until rash subsides and restart at half the dose, slowly increasing to 4 sprays, twice daily if tolerance allows